Shopping Cart
- Remove All
- Your shopping cart is currently empty
Zalutumumab is a high-affinity fully human monoclonal antibody that targets the extracellular domain of the epidermal growth factor receptor (EGFR) and is used to treat squamous cell carcinoma of the head and neck (SCCHN).
Pack Size | Price | Availability | Quantity |
---|---|---|---|
1 mg | $215 | In Stock | |
5 mg | $556 | In Stock | |
10 mg | $888 | In Stock |
Description | Zalutumumab is a high-affinity fully human monoclonal antibody that targets the extracellular domain of the epidermal growth factor receptor (EGFR) and is used to treat squamous cell carcinoma of the head and neck (SCCHN). |
In vitro | Methods: A431 cell line was treated with zalutumumab (0-1 μM, 96 hours) and cell viability was measured. Results: Zalutumumab inhibited A431 cell proliferation with an IC50 value of 1.5 nM. [1] |
In vivo | Zalutumumab (5 mg/kg, intraperitoneal injection 2 hours after tumor induction) can affect tumor growth in A431 xenograft model mice.[1] |
Cas No. | 667901-13-5 |
Storage | store at low temperature | store at -20°C | Shipping with blue ice/Shipping at ambient temperature. |
Copyright © 2015-2025 TargetMol Chemicals Inc. All Rights Reserved.